A new mechanism in potassium channel blockage identified for a scorpion venom peptide

Publish Year: 1400
نوع سند: مقاله کنفرانسی
زبان: English
View: 167

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

IBIS10_227

تاریخ نمایه سازی: 5 تیر 1401

Abstract:

Background: Scorpion venom is a source of ion channel modifier peptides with interesting pharmacologicalproperties. Here, in addition to reporting the structure of a peptide(meuK۲-۲), identified in the Mesobuthuseupeus venom gland, its interaction with Kv۱.۳ channel was also interpreted.Methods: Three-dimensional structure of meuK۲-۲ was generated using MODELLER and I-TASSER,PHYRE۲, Robetta servers. The best model was selected according to Z-score;and considered for furtheroptimization using MD simulation.Interaction of meuK۲-۲ with the Kv۱.۳ channel was also evaluated usingpeptide-protein docking experiments with HADDOCK software, subsequently pose clustering and also, ۱۰۰ns MD simulations using a protein-water system in the NVT ensemble by Gromacs to evaluate the bindinginteraction between meuK۲-۲ and Kv۱.۳.The final docked complexes were then subject to minimization withCHARMM force field and investigated key interacting residues, electrostatic interactions, binding freeenergies, folding pattern, hydrogen bond formation, hydrophobic contacts.Results: ۳-D structure of the meuK۲-۲ is composed of a cysteine-stabilized α-helical and β-sheet(CSα/β)folding.Two key residues and H-bonds are involved in the binding of meuK۲-۲ to Kv۱.۳.In a new mechanismmeuK۲-۲ binds to both turret and pore loop of the channel.The binding of meuK۲-۲ induces someconformational changes to Kv۱.۳. This is followed by occupation of the pore of the channel with the sidechain of a His۹ residue.Altogether blocks the ion permeation pathway.Conclusions: A new mechanism was predicted for channel blocking with meuK۲-۲.Since Kv۱.۳ plays asignificant role in human T cell activation, meuK۲-۲ have a potential for further investigations to develop asa pharmacological tool in treatment of autoimmune diseases.

Authors

Masoumeh Baradaran

Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran